Michael McGillis
About Michael McGillis
Michael McGillis, 63, is President and Chief Financial Officer of Claros Mortgage Trust (CMTG) and has served as President and director since March 2022; he previously served as President, CFO and director of CMTG. He is President of Mack Real Estate Group (MREG), a member of the Investment Committees of MREG and Mack Real Estate Credit Strategies (MRECS), graduated magna cum laude from Northeastern University, and is a CPA (inactive) . CMTG is externally managed with no employees; NEO cash pay is set and paid by the Manager, with company-awarded compensation primarily via time-vested RSUs; the Manager considers Distributable Earnings, Net Income/Loss and TSR in its discretion (no fixed weights) . Company performance context: cumulative TSR fell to $35.72 (from a fixed $100 base since NYSE listing) in 2024 alongside Net Loss of $(221.27)m and Distributable Loss of $(95.65)m; 2023 saw modest gains; 2022 was positive on both GAAP and Distributable metrics .
Past Roles
| Organization | Role | Years | Strategic impact |
|---|---|---|---|
| Mack Real Estate Group / MRECS | President of MREG; formerly President & COO; member of Investment Committees (MREG, MRECS) | 2015–present | Senior leadership and investment oversight across credit and real estate platforms |
| J.E. Robert Companies (JER) | Managing Director, Head of U.S. Funds and CFO | 2011–2015 | Oversaw asset/portfolio management, capital markets and finance for U.S./EU private equity RE funds (> $4B equity commitments) |
| JER (prior roles) | CFO (JER), CFO (U.S. fund business), CFO (JER Investors Trust; director) | 2006–2011 | Finance leadership at mortgage REIT and fund businesses; investment/valuation committee participation |
| Earlier employers | Freddie Mac; Starcom Holdings; AEW Capital Management; Robertson-Ceco; Price Waterhouse | n/a | Senior finance and investment roles across mortgage finance, investments, and accounting |
External Roles
| Organization | Role | Years | Strategic impact |
|---|---|---|---|
| Tom Coughlin Jay Fund | Director | n/a | Non-profit governance |
| MREG/MRECS | Investment Committee member (both) | n/a | Credit/investment decision-making across affiliated platforms |
Fixed Compensation
| Component | 2024 | 2023 | 2022 | Notes |
|---|---|---|---|---|
| Base salary (paid by CMTG) | $0 | $0 | $0 | CMTG has no employees; cash pay set/paid by Manager; CMTG may reimburse allocable CFO/non-investment personnel costs under Management Agreement; individual base/bonus at Manager not disclosed |
| Target bonus (%) | Not disclosed | Not disclosed | Not disclosed | Manager determines form/level of pay; CMTG does not set cash targets |
| Actual bonus (paid by CMTG) | $0 | $0 | $0 | No company cash bonus to McGillis |
| Equity grant date fair value (RSUs) | $836,270 | $903,661 | $3,366,605 | Time-based RSUs under 2016 Plan |
Performance Compensation
-
Structure and metrics
- Manager used discretionary factors in 2024 (no fixed weights): Distributable Earnings (Loss), Net Income (Loss), and TSR; NEO equity awards are time-vested RSUs (no PSUs/options) .
-
Annual equity grants and vesting | Grant | Grant date | Type | Shares granted | Vesting schedule | Notes | |---|---|---|---:|---|---| | 2024 award | 3/25/2024 | RSUs | 86,750 | 1/3 on 4/1/2025, 1/3 on 4/1/2026, 1/3 on 4/1/2027 (service-based) | Dividend equivalents on unvested RSUs | | 2023 award | 3/30/2023 | RSUs | Not disclosed | 1/3 vested 4/1/2024; remaining vest 4/1/2025 and 4/1/2026 (service-based) | Time-based; death/disability accelerates | | 2022 award | 6/14/2022 | RSUs | Not disclosed | 1/3 vested 7/1/2023; 1/3 vested 7/1/2024; remaining vests 7/1/2025 (service-based) | Time-based; death/disability accelerates |
-
Pay versus performance context (company-level) | Year | Cumulative TSR ($) | Net Income (Loss) ($mm) | Distributable Earnings (Loss) ($mm) | |---|---:|---:|---:| | 2022 | 97.63 | 112.06 | 194.35 | | 2023 | 100.41 | 6.03 | 39.94 | | 2024 | 35.72 | (221.27) | (95.65) |
-
Change in control and termination treatment
- Equity accelerates on death/disability; upon a change in control, unassumed/substituted awards vest immediately (single-trigger if not assumed; otherwise continue) .
Equity Ownership & Alignment
| Item | Detail |
|---|---|
| Beneficial ownership (common) | 302,589 shares; <1% of outstanding |
| Unvested RSUs (12/31/2024) | 200,012 RSUs ($904,054 at $4.52/sh) |
| 2024 RSUs vested | 86,602 shares; value realized $728,072; 52,523 shares delivered after tax (sell-to-cover via share withholding) |
| Options | None outstanding (company-wide, NEOs held no options in 2024) |
| Hedging/pledging | Prohibited (no options trading/shorts; hedging and pledging barred; no margin purchases) |
| Ownership guidelines | Director guidelines = 3x cash retainer; executive officer ownership guidelines not disclosed |
- Upcoming vesting cadence (potential sell-to-cover supply)
- 7/1/2025: final tranche from 2022 grant (service-based)
- 4/1/2025 and 4/1/2026: remaining 2023 tranches
- 4/1/2025, 4/1/2026, 4/1/2027: 2024 tranches
Implication: Time-based tranches through 2027 create recurring settlement events; historical 2024 net share settlement indicates tax withholdings rather than open-market selling, moderating direct selling pressure .
Employment Terms
| Topic | Details |
|---|---|
| Employment status | Externally managed; executives employed by Manager/affiliates, not by CMTG |
| Start/tenure | President and director since March 2022; serves as President and CFO currently |
| Contracts | CMTG does not have executive employment agreements; Manager sets pay |
| Severance (cash) | None from CMTG for CEO/President/CFO; no severance cash arrangements disclosed for executives |
| Equity upon termination | Death/disability: unvested RSUs vest; CIC: if awards not assumed/substituted, they vest at CIC |
| Non-compete/solicit | Not disclosed |
| Clawback policy | Dodd-Frank-compliant policy covering time- and performance-vesting equity and other incentive pay for Section 16 officers (from Oct 2, 2023) |
| Deferred comp | Executives may defer RSU settlement into Deferred Stock Units; no executive deferrals in 2024 |
Board Governance
- Role: Inside director (President & CFO); not independent due to executive and Manager affiliations .
- Committees: Audit, Compensation, and Nominating committees are fully independent; current members exclude executives .
- Board leadership: CEO Richard Mack is Chairman; Lead Independent Director (W. Edward Walter III) presides over independent sessions and agenda-setting .
- Attendance: In 2024, all directors then serving attended at least 75% of Board and committee meetings .
- Director pay: Executive directors (Mack, McGillis) receive no additional director compensation; independent director program includes cash retainers and annual RSU grant (raised to $125k value in 2025) .
Dual-role implications: McGillis holds an executive office and board seat (non-independent), while the CEO is also Chair; mitigants include a Lead Independent Director and independent key committees with active oversight .
Director Compensation (as applicable to McGillis)
| Item | 2024 |
|---|---|
| Board retainer | $0 (no additional compensation for executive directors) |
| Equity for director service | $0 (executive directors excluded from non-employee director RSUs) |
Say-on-Pay & Shareholder Feedback
| Year | Say-on-Pay approval |
|---|---|
| 2024 | ~83% of votes cast supported executive compensation |
Compensation Committee & Consultants
- 2024 Compensation Committee: Vincent Tese (Chair), Derrick D. Cephas, Pamela Liebman; all independent .
- Consultant: Farient Advisors engaged to advise on 2025 equity pool sizing; committee assessed independence and found no conflicts .
Related Party & Management Agreement Considerations
- External management: Base fee 1.5% of stockholders’ equity (quarterly), plus quarterly incentive fee equal to 20% of Core Earnings over a 7% annualized hurdle, measured on rolling four quarters, floor at zero; incentive not payable unless 12-quarter Core Earnings > 0 .
- 2024 fees and reimbursements: ~$36.2m management/incentive fees; ~$4.3m reimbursed expenses; payables at year-end included ~$27.0m of fees and ~$3.1m reimbursables .
- Term and termination: Agreement through earlier of Aug 25, 2025 or complete disposition; termination by Manager after company default triggers termination fee equal to 3x average annual base + incentive fees over prior 24 months; company may terminate for specified “cause” events without fee .
Compensation Structure Analysis
- Mix shift and risk
- Time-vested RSUs dominate company-awarded comp; no disclosed PSUs or options; reduces performance leverage but supports retention through multi-year vesting .
- Manager used discretionary metrics rather than fixed targets or weightings; can weaken pay-for-performance transparency and tie .
- Discretionary outcomes vs results
- 2024 saw significant TSR drawdown and losses, while RSUs continued to vest/grant; “compensation actually paid” to NEOs (average) was negative given stock price effects, indicating partial market alignment through mark-to-market valuation of equity .
- Repricing/modification
- No disclosure of option repricing or award modifications; NEOs held no options in 2024 .
Risk Indicators & Red Flags
- Alignment and fee structure: External management with incentive fee over a 7% hurdle (20% share) and a sizable termination fee may create potential conflicts versus common shareholders; close monitoring of fee economics is warranted .
- Performance-linkage: No fixed performance metrics or PSUs; reliance on time-based RSUs and discretionary Manager judgments may dilute explicit pay-for-performance .
- Governance: CEO-Chair duality and an inside director (McGillis) reduce board independence at the top, though Lead Independent Director and independent committees provide mitigants .
- Hedging/pledging: Prohibited (reduces misalignment risk) .
- Related parties: Multiple large shareholders and affiliates represented historically; ongoing independence determinations disclosed -.
Investment Implications
- Retention and selling pressure: McGillis has 200,012 unvested RSUs with scheduled vesting through 2027; 2024 settlement behavior shows net share settlement with tax withholding rather than open-market sales, suggesting limited direct selling pressure but recurring supply around vest dates (notably 4/1 and 7/1 windows) .
- Alignment: Significant equity exposure via RSUs and company stock (302,589 beneficially owned) supports alignment, but absence of performance-vesting awards and the external fee structure reduce direct linkage to shareholder value creation .
- Governance: Inside director status and CEO-Chair combination merit ongoing scrutiny; mitigated by Lead Independent Director and independent committees with regular meetings and oversight -.
- Shareholder sentiment: 83% say-on-pay support in 2024 indicates moderate investor acceptance; however, 2024 TSR and losses heighten the importance of disciplined capital allocation and fee oversight .